COMMUNIQUÉS West-GlobeNewswire

Rein Therapeutics Receives Orphan Drug Designation from European Medicines Agency for Lead Drug Candidate in Idiopathic Pulmonary Fibrosis
20/01/2026
-- Designation highlights significant unmet medical need AUSTIN, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in- [...]
Cogent Biosciences to Initiate New Drug Application (NDA) Submission for Bezuclastinib Under Real-Time Oncology Review (RTOR)
20/01/2026
- PEAK trial first ever study to demonstrate statistical significance over an active comparator in GIST patients, with bezuclastinib plus sunitinib combination demonstrating mPFS of 16.5 months and ORR of 46% in [...]
SpyGlass Pharma Announces First Patients Randomized in SGP-005 and SGP-006, Two Registrational Phase III Clinical Trials of Its Novel BIM-IOL System
20/01/2026
ALISO VIEJO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical [...]
Korro to Host Virtual Analyst Day on January 27, 2026
20/01/2026
- Program to feature presentations from the company management about KRRO-121 for the potential treatment of hyperammonemia , a leading clinical hepatologist about ammonia-driven diseases, and a caregiver sharing [...]
Catheter Precision Received new VIVO Purchase Order from Leading Hospital in Slovenia
20/01/2026
Expands Global Footprint to 15 Countries FORT MILL, S.C., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically [...]
electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million
20/01/2026
Record revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0 - $9.2 million for the three months ended December 31, 2025 Revenue growth of approximately 26% over full-year 2024 Cash, [...]
Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership
20/01/2026
Industry veteran brings decades of experience in artificial intelligence, digital transformation and large-scale technology operations to support Alignment’s next phase of growth ORANGE, Calif., Jan. 20, 2026 (GLOBE [...]
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
20/01/2026
BOCA RATON, Fla., Jan. 20, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical-stage pharmaceutical company advancing LB-100, a first-in-class inhibitor of [...]
Nasus Pharma Announces Positive Interim Results from Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
20/01/2026
Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to EpiPen ® 91% of study participants achieved the 100 pg/ml plasma threshold at 5 minutes with [...]
Spur Therapeutics Announces Platform and Poster Presentations Highlighting New Clinical Data for FLT201 in Gaucher Disease at Upcoming WORLDSymposium™
20/01/2026
LONDON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced that it will share updated clinical data from its Phase 1/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its Phase 3 gene [...]
CorVel Corporation to Host Live Earnings Release Webcast
20/01/2026
FORT WORTH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its [...]
FOXO Technologies Inc. Subsidiary, Big South Fork Medical Center, Expands Clinical Capabilities
20/01/2026
WEST PALM BEACH, FL, Jan. 20, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (“FOXO” or the “Company”) today announced that its critical access-designated acute care hospital, Scott County Community [...]
Machina Medical Receives FDA 510(k) Clearance for MFUSE External Bleeding Control Device
20/01/2026
ROSWELL, Ga., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Machina Medical, Corp. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MFUSE, a sterile, single-use medical device [...]
Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes
20/01/2026
Partnership evolution includes strategic integration of select Novo Nordisk technologies into Aspect Biosystems Aspect will lead development, manufacturing and commercialisation, and Novo Nordisk will have defined [...]
Radix Health Rebrands as Pivotal Health
20/01/2026
Following rapid adoption of its Independent Dispute Resolution technology, Pivotal Health broadens its mission to help providers achieve fair reimbursement through technology NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- [...]
RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center
20/01/2026
MOUNTAIN VIEW, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies, today announced continued [...]
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
20/01/2026
If granted, QRX003 could be approved for sale and reimbursement in Saudi Arabia as a treatment for Netherton Syndrome in 2H 2026 QRX003 could become the first ever approved treatment for Netherton Syndrome ASHBURN, Va [...]
BrightInsight Announces Multi-Million Dollar Strategic Investment to Advance its AI-Enabled Medication Persistence and Adherence Solutions
20/01/2026
SAN JOSE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- BrightInsight , a leader in digital health solutions, today announced a new investment round of $13 million from existing and new investors including Eclipse, General [...]
InStride Health and The Wharton School Showcase Successful AI Scribe Adoption for Improved Clinician Efficiency and Experience
20/01/2026
Case study highlights how collaboration from clinical and technical teams drive effective, responsible, and scalable AI adoption in behavioral health BOSTON and PHILADELPHIA, Jan. 20, 2026 (GLOBE NEWSWIRE) -- InStride [...]

Pages